The impact of thyroid hormone dysfunction on ischemic heart disease
Open Access
- 1 May 2019
- journal article
- review article
- Published by Bioscientifica in Endocrine Connections
- Vol. 8 (5) , R76-R90
Abstract
Thyroid hormones have a central role in cardiovascular homeostasis. In myocardium, these hormones stimulate both diastolic myocardial relaxation and systolic myocardial contraction, have a pro-angiogenic effect and an important role in extracellular matrix maintenance. Thyroid hormones modulate cardiac mitochondrial function. Dysfunction of thyroid axis impairs myocardial bioenergetic status. Both overt and subclinical hypothyroidism are associated with a higher incidence of coronary events and an increased risk of heart failure progression. Endothelial function is also impaired in hypothyroid state, with decreased nitric oxide-mediated vascular relaxation. In heart disease, particularly in ischemic heart disease, abnormalities in thyroid hormone levels are common and are an important factor to be considered. In fact, low thyroid hormone levels should be interpreted as a cardiovascular risk factor. Regarding ischemic heart disease, during the late post-myocardial infarction period, thyroid hormones modulate left ventricular structure, function and geometry. Dysfunction of thyroid axis might even be more prevalent in the referred condition since there is an upregulation of type 3 deiodinase in myocardium, producing a state of local cardiac hypothyroidism. In this focused review, we summarize the central pathophysiological and clinical links between altered thyroid function and ischemic heart disease. Finally, we highlight the potential benefits of thyroid hormone supplementation as a therapeutic target in ischemic heart disease.Keywords
This publication has 132 references indexed in Scilit:
- The deiodinases and the control of intracellular thyroid hormone signaling during cellular differentiationBiochimica et Biophysica Acta (BBA) - General Subjects, 2013
- Improvement of left ventricular remodeling after myocardial infarction with eight weeks L-thyroxine treatment in ratsJournal of Translational Medicine, 2013
- Gene Specific Actions of Thyroid Hormone Receptor SubtypesPLOS ONE, 2013
- Left and right ventricular structure and function in subclinical hypothyroidism: The effects of one-year levothyroxine treatmentMedical Science Monitor, 2013
- State of the art paper Hyperthyroidism and cardiovascular complications: a narrative review on the basis of pathophysiologyArchives of Medical Science, 2013
- Targeting p53 via JNK Pathway: A Novel Role of RITA for Apoptotic Signaling in Multiple MyelomaPLOS ONE, 2012
- In Vivo Activity of the Thyroid Hormone Receptor β- and α-Selective Agonists GC-24 and CO23 on Rat Liver, Heart, and BrainEndocrinology, 2011
- The role of thyroid hormone nuclear receptors in the heart: evidence from pharmacological approachesHeart Failure Reviews, 2008
- Myocardial repair/remodelling following infarction: roles of local factorsCardiovascular Research, 2008
- Short term triiodo-l-thyronine treatment inhibits cardiac myocyte apoptosis in border area after myocardial infarction in ratsJournal of Molecular and Cellular Cardiology, 2008